FLUORESCENCE IMAGING CAPABILITIES IN SECONDARY LYMPHEDEMA FOLLOWING COMPREHENSIVE TREATMENT OF MALIGNANT NEOPLASMS: A CASE SERIES

2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.11134/btp.3.2026.39
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Background. Secondary upper limb lymphedema is a complication of multimodal treatment for malignant neoplasms associated with damage to the regional lymphatic system. Indocyanine green (ICG) fluorescence lymphography enables real-time visualization of superficial lymphatic vessels and assessment of lymphatic drainage patterns. However, data on fluorescence patterns in secondary lymphedema of different oncological etiologies and their clinical significance remain limited. Objective. To evaluate the diagnostic potential of ICG fluorescence lymphography for detecting and characterizing lymphatic drainage abnormalities in female patients with secondary upper limb lymphedema following multimodal treatment for malignant neoplasms. Materials and Methods. A case series of 10 female patients with secondary upper limb lymphedema following treatment for breast cancer (n = 7), melanoma (n = 2), and cutaneous squamous cell carcinoma (n = 1) was analyzed. The duration of lymphedema before examination ranged from 3 months to 2–3 years. All patients underwent ICG fluorescence lymphography. Results. Fluorescence lymphography revealed four lymphatic drainage patterns: a linear pattern and three types of dermal backflow, namely splash, stardust, and diffuse patterns. The characteristics and extent of fluorescence abnormalities reflected the underlying alterations in lymphatic drainage. Visualization of preserved lymphatic collectors enabled identification of their anatomical location and potential sites for lymphovenous anastomosis. Conclusion. ICG fluorescence lymphography enabled characterization of lymphatic drainage abnormalities and visualization of preserved superficial lymphatic collectors. The findings demonstrated the potential utility of this technique for assessing lymphatic dysfunction, individualizing treatment strategies, and facilitating preoperative planning of lymphovenous anastomosis.